ACTG Network Monthly Newsletter - August 2016

Published Date:

08/30/2016

Publication:

ACTG

Women's Outreach Workers Project Releases New Educational Video


New Video Addresses Questions Women and Minorities May Have Regarding ACTG Network Clinical Trials

The Women's Outreach Workers (WOW) Project was established with the goal of developing optimal strategies for increasing recruitment and retention of women, particularly women of color in ACTG Network clinical trials. Led by Susan E. Cohn, MD, MPH, Investigator at our Northwestern University Site, and working in collaboration with the Women's Health Inter-Network Scientific Committee (WHISC) and the Underrepresented Populations Committee (UPC), the WOW Project team created an educational video to help to answer many questions women and minorities may have about participating in ACTG Network clinical trials.


Click HERE for the rest of the article and to view the video.

Clinical Trials

A5342: Evaluating the Safety, Tolerability, and Effect of a...

The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...

Read More

HPTN 069: A Phase II Randomized, Double-Blind, Study of the...

HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...

Read More

A5320: Viral Hepatitis C Infection Long-term Cohort Study...

A5320/V-HICS is an observational, prospective, long-term follow-up study in hepatitis C virus (HCV) monoinfected and HCV/HIV-1...

Read More

P1073: Study of Immune Reconstitution Inflammatory Syndrome...

P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...

Read More

P1077FF: Formula Feeding Version of the PROMISE Study...

1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...

Read More